| 211 |
Handbook development AOP |
Dan Villeneuve |
BY-SA |
None
|
None
|
|
|
| 192 |
Pendrin inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1155: Inhibition, Pendrin
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 183 |
Nosema infection increases energetic demands leading to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 163 |
PPARgamma activation leading to sarcomas in rats, mice, and hamsters |
Charles Wood |
BY-SA |
1028: Activation of specific nuclear receptors, PPAR-gamma activation
|
None
|
|
|
| 185 |
Queen egg-laying decrease leads to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 186 |
unknown MIE leading to renal failure and mortality |
Kellie Fay |
BY-SA |
1114: Unknown, MIE
|
351: Increased Mortality
|
|
|
| 188 |
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1152: Inhibition, Iodotyrosine deiodinase (IYD)
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 189 |
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1009: Inhibition, Deiodinase 1
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 190 |
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1002: Inhibition, Deiodinase 2
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 191 |
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1153: Inhibition, Deiodinase 3
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 184 |
Nosema infection causes abnormal role change that leads to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 193 |
Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1156: Inhibition, Dual oxidase
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 194 |
Hepatic nuclear receptor activation leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1157: Activation, Hepatic nuclear receptor(s)
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 195 |
5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase |
Kellie Fay |
BY-SA |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)
|
1164: Increased, Population
|
|
|
| 197 |
Sodium channel (Nav1.1) inhibition leading to population decline |
Kellie Fay |
BY-SA |
584: Inhibition, sodium channel
|
None
|
|
|
| 199 |
ER mediated breast cancer AOP |
Molly M Morgan |
BY-SA |
None
|
None
|
|
|
| 203 |
5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline |
Kellie Fay |
BY-SA |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)
|
2 AOs
|
|
|
| 204 |
5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase |
Kellie Fay |
BY-SA |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)
|
2 AOs
|
|
|
| 170 |
Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the SD rat |
Charles Wood |
BY-SA |
None
|
1079: Increased, Adenomas/carcinomas (mammary)
|
|
|
| 164 |
Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse |
Charles Wood |
BY-SA |
1038: Activation, beta-2 adrenergic receptor
|
1044: Promotion, mesovarian leiomyomas
|
|
|
| 165 |
Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse |
Charles Wood |
BY-SA |
None
|
2 AOs
|
|
|
| 166 |
PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse |
Charles Wood |
BY-SA |
None
|
1063: Increased, Pancreatic acinar tumors
|
|
|
| 167 |
Early-life estrogen receptor agonism leading to endometrial adenosquamous carcinoma via promotion of sine oculis homeobox 1 progenitor cells |
Travis Karschnik |
BY-SA |
111: Agonism, Estrogen receptor
|
1070: Increased, adenosquamous carcinomas of endometrium
|
|
|
| 168 |
GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat. |
Charles Wood |
BY-SA |
None
|
1079: Increased, Adenomas/carcinomas (mammary)
|
|
|
| 169 |
GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat. |
Charles Wood |
BY-SA |
None
|
1082: Increased, adenomas (pituitary)
|
|
|